Supporting the

Neuroendocrine Cancer Community

INCA launches new website Research page

INCA launches new website Research page

INCA has launched the new Research Section on www.incalliance.org INCA is committed to empower NET patients to bring robust participation in clinical trials and to play an active role in shaping patient-centered research. INCA seeks to advocate for patient involvement...
Kate Quirk – INCA Research Committee

Kate Quirk – INCA Research Committee

Kate Quirk, Neuroendocrine Cancer UK Patient Support Coordinator, has just been appointed to the INCA Research Committee, after contributing to the completion of a project to bring wider access to Clinical Trials for Neuroendocrine Cancer patients globally. INCA (the...
INCA – New Factsheets

INCA – New Factsheets

INCA (The International Neuroendocrine Cancer Alliance) has released six new factsheets including; genetic NET syndromes, Pheochromocytoma (pheo) and paraganglioma (para), and sporadic Pheo and para in their NETInfo multilingual library, which now offers a total of 26...
The Impact of COVID-19 on the Management of NETS

The Impact of COVID-19 on the Management of NETS

INCA Supported a Study on the Impact of COVID-19 on NET Management, Now Published in the Journal of Neuroendocrinology An abstract of a study with the active involvement of the global neuroendocrine tumor (NET) community was published in the Journal of...